Impact of a New Formulation of Low-Dose Micronised Medroxyprogesterone and 17- Estradiol on Lipid Profiles in Menopausal Women

Author： Harrison R.F.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.16, Iss.2, 1998-08, pp. : 93-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS ( R)), with commercial lipid-based formulations

By Fukui H.   Koike T.   Nakagawa T.   Saheki A.   Sonoke S.   Tomii Y.   Seki J.  

International Journal of Pharmaceutics, Vol. 267, Iss. 1, 2003-11 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite

Effects of Low-Dose Atorvastatin and Rosuvastatin on Plasma Lipid Profiles: A Long-Term, Randomized, Open-Label Study in Patients with Primary Hypercholesterolemia

By Mazza Fabio   Stefanutti Claudia   Serafina Di Giacomo   Vivenzio Antonio   Fraone Nadia   Mazzarella Bruno   Bucci Antonello  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 265-270

Adis International

Access to resources Recommend Favorite

17β-Estradiol/levonorgestrel transdermal system for the management of the symptomatic menopausal woman

By Shulman Lee P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2559-2566

Informa Healthcare

Access to resources Recommend Favorite

Low-dose estrogens prevent bone loss in postmenopausal women

By  

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Medroxyprogesterone ± estradiol cipionate: effect on BMD

By  

Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite